🇫🇷
France · FR · FR:65648219
GEFITINIB MYLAN 250 mg, comprimé pelliculé
ReimbursedATC L01EB01
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerMYLAN PHARMACEUTICALS (IRLANDE)
CountryFR (France)
ATC codeL01EB01
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340093015666730 plaquettes thermoformée(s) PVC PVDC aluminium de 1 compriméEUR 754.65
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "65648219",
"date_amm": "2018-09-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/18/1321",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L01EB01.
- CAAPO-GEFITINIBAPOTEX INC
- 🇺🇸GefitinibIngenus Pharmaceuticals, LLC
- 🇺🇸GefitinibNatco Pharma USA LLC
- 🇺🇸GefitinibTeva Pharmaceuticals, Inc.
- 🇺🇸GefitinibQilu Pharmaceutical Co., Ltd.
- DKGefitinib "Accord"Accord Healthcare B.V.
- DKGefitinib "Mylan"Mylan Pharmaceuticals Limited
- DKGefitinib "Stada"STADA Arzneimittel AG
Access this data programmatically
Query GEFITINIB MYLAN 250 mg, comprimé pelliculé and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.